Dietary supplement study for bowel issues and metabolic syndrome
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests if a dietary supplement can help people with both irritable bowel syndrome (IBS) and metabolic syndrome. It aims to improve gut health and reduce related risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had belly pain at least once a week for the past 3 months, and it's linked to bowel movements, changes in how often you go, or changes in stool appearance.
- You have at least two signs of metabolic syndrome, like high blood sugar, large waist size (or high BMI), high blood pressure, low good cholesterol, high triglycerides, or protein in your urine.
- You are not allergic to any ingredients in the supplement.
- You have not been diagnosed with metabolic syndrome before.
- You have never had a stroke or heart attack.
- You do not have mood disorders, kidney disease, intestinal disease, pancreatitis, diabetes, or other endocrine problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a dietary supplement designed for people with metabolic syndrome. It aims to see if the supplement can help improve key markers of metabolic health, like blood sugar and cholesterol levels.
This trial tests whether foods with antioxidants, prebiotic fibers, and oat beta-glucans can help people who are at risk for metabolic syndrome. It looks at measures like waist size, blood sugar, blood pressure, and cholesterol to see if these foods improve health markers.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
This trial tests whether a synbiotic (a mix of probiotics and prebiotics) called Vivatlac can improve gut health in people with moderate to severe irritable bowel syndrome (IBS). If you have IBS and are not already taking probiotics or antibiotics, you may be able to join.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
This trial tests a combination of digestive enzymes and probiotics (called Enzymax DuoBiotics) to see if it can help people with irritable bowel syndrome (IBS) feel better. If you have IBS and are between 18 and 70, this study may be a good fit.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.